nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—head and neck cancer	0.461	1	CiPCiCtD
Gemcitabine—TYMS—head and neck cancer	0.169	1	CbGaD
Gemcitabine—RRM2—Hydroxyurea—head and neck cancer	0.107	0.388	CbGbCtD
Gemcitabine—RRM1—Hydroxyurea—head and neck cancer	0.107	0.388	CbGbCtD
Gemcitabine—SLC29A1—Fluorouracil—head and neck cancer	0.0235	0.0851	CbGbCtD
Gemcitabine—TYMS—Fluorouracil—head and neck cancer	0.0217	0.0789	CbGbCtD
Gemcitabine—ABCC10—Docetaxel—head and neck cancer	0.0137	0.0497	CbGbCtD
Gemcitabine—ABCB1—Vinblastine—head and neck cancer	0.00155	0.00561	CbGbCtD
Gemcitabine—RRM1—larynx—head and neck cancer	0.00129	0.0742	CbGeAlD
Gemcitabine—ABCB1—Docetaxel—head and neck cancer	0.00127	0.00463	CbGbCtD
Gemcitabine—POLD1—exocrine gland—head and neck cancer	0.00104	0.0601	CbGeAlD
Gemcitabine—CMPK1—hair follicle—head and neck cancer	0.000794	0.0457	CbGeAlD
Gemcitabine—POLD1—mouth—head and neck cancer	0.000781	0.045	CbGeAlD
Gemcitabine—POLD1—neck—head and neck cancer	0.000668	0.0384	CbGeAlD
Gemcitabine—Pulmonary fibrosis—Hydroxyurea—head and neck cancer	0.000553	0.0134	CcSEcCtD
Gemcitabine—Cardiotoxicity—Docetaxel—head and neck cancer	0.000537	0.013	CcSEcCtD
Gemcitabine—POLD1—saliva-secreting gland—head and neck cancer	0.000521	0.03	CbGeAlD
Gemcitabine—Lung infiltration—Hydroxyurea—head and neck cancer	0.000519	0.0126	CcSEcCtD
Gemcitabine—Cutaneous hypersensitivity—Docetaxel—head and neck cancer	0.000518	0.0125	CcSEcCtD
Gemcitabine—RRM1—hair follicle—head and neck cancer	0.000509	0.0293	CbGeAlD
Gemcitabine—Acute respiratory distress syndrome—Docetaxel—head and neck cancer	0.000484	0.0117	CcSEcCtD
Gemcitabine—RRM2—mouth—head and neck cancer	0.000481	0.0277	CbGeAlD
Gemcitabine—Colitis ischaemic—Docetaxel—head and neck cancer	0.00043	0.0104	CcSEcCtD
Gemcitabine—RRM2—Vinorelbine—Vinblastine—head and neck cancer	0.000427	0.407	CbGdCrCtD
Gemcitabine—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.000405	0.00978	CcSEcCtD
Gemcitabine—Eruption—Hydroxyurea—head and neck cancer	0.000396	0.00957	CcSEcCtD
Gemcitabine—POLE—saliva-secreting gland—head and neck cancer	0.000389	0.0224	CbGeAlD
Gemcitabine—Hypomagnesaemia—Hydroxyurea—head and neck cancer	0.000383	0.00926	CcSEcCtD
Gemcitabine—CMPK1—connective tissue—head and neck cancer	0.000382	0.022	CbGeAlD
Gemcitabine—SLC28A3—trachea—head and neck cancer	0.000368	0.0212	CbGeAlD
Gemcitabine—Neuritis—Vinblastine—head and neck cancer	0.000357	0.00864	CcSEcCtD
Gemcitabine—POLA1—parotid gland—head and neck cancer	0.00035	0.0202	CbGeAlD
Gemcitabine—POLD1—lymphoid tissue—head and neck cancer	0.00035	0.0201	CbGeAlD
Gemcitabine—Breast cancer—Docetaxel—head and neck cancer	0.000347	0.00838	CcSEcCtD
Gemcitabine—Neurotoxicity—Docetaxel—head and neck cancer	0.000326	0.00789	CcSEcCtD
Gemcitabine—POLD1—thyroid gland—head and neck cancer	0.000318	0.0183	CbGeAlD
Gemcitabine—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.000315	0.00762	CcSEcCtD
Gemcitabine—CDA—lymphoid tissue—head and neck cancer	0.000314	0.0181	CbGeAlD
Gemcitabine—Extravasation—Vinblastine—head and neck cancer	0.000306	0.0074	CcSEcCtD
Gemcitabine—POLE—trachea—head and neck cancer	0.0003	0.0173	CbGeAlD
Gemcitabine—Cellulitis—Vinblastine—head and neck cancer	0.000293	0.0071	CcSEcCtD
Gemcitabine—Febrile neutropenia—Fluorouracil—head and neck cancer	0.000291	0.00704	CcSEcCtD
Gemcitabine—Pulmonary fibrosis—Docetaxel—head and neck cancer	0.000287	0.00695	CcSEcCtD
Gemcitabine—CDA—thyroid gland—head and neck cancer	0.000285	0.0164	CbGeAlD
Gemcitabine—TYMS—Paclitaxel—Docetaxel—head and neck cancer	0.000284	0.27	CbGdCrCtD
Gemcitabine—POLD1—head—head and neck cancer	0.000282	0.0162	CbGeAlD
Gemcitabine—CMPK1—lymphoid tissue—head and neck cancer	0.000279	0.0161	CbGeAlD
Gemcitabine—Tenderness—Hydroxyurea—head and neck cancer	0.000279	0.00675	CcSEcCtD
Gemcitabine—Bone pain—Vinblastine—head and neck cancer	0.000279	0.00674	CcSEcCtD
Gemcitabine—Raised liver function tests—Docetaxel—head and neck cancer	0.000274	0.00662	CcSEcCtD
Gemcitabine—SLC29A2—thyroid gland—head and neck cancer	0.000267	0.0154	CbGeAlD
Gemcitabine—Interstitial pneumonia—Docetaxel—head and neck cancer	0.000262	0.00633	CcSEcCtD
Gemcitabine—POLE—lymphoid tissue—head and neck cancer	0.000262	0.0151	CbGeAlD
Gemcitabine—Ulcer—Hydroxyurea—head and neck cancer	0.000257	0.00622	CcSEcCtD
Gemcitabine—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.000257	0.00622	CcSEcCtD
Gemcitabine—Creatinine increased—Hydroxyurea—head and neck cancer	0.000256	0.00618	CcSEcCtD
Gemcitabine—CMPK1—thyroid gland—head and neck cancer	0.000254	0.0146	CbGeAlD
Gemcitabine—Lymphopenia—Docetaxel—head and neck cancer	0.000247	0.00598	CcSEcCtD
Gemcitabine—POLE—thyroid gland—head and neck cancer	0.000238	0.0137	CbGeAlD
Gemcitabine—Skin exfoliation—Hydroxyurea—head and neck cancer	0.000232	0.00562	CcSEcCtD
Gemcitabine—Blood urea increased—Hydroxyurea—head and neck cancer	0.00023	0.00556	CcSEcCtD
Gemcitabine—CMPK1—head—head and neck cancer	0.000225	0.013	CbGeAlD
Gemcitabine—TYMS—connective tissue—head and neck cancer	0.000222	0.0128	CbGeAlD
Gemcitabine—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.000217	0.00524	CcSEcCtD
Gemcitabine—Deafness—Vinblastine—head and neck cancer	0.000217	0.00524	CcSEcCtD
Gemcitabine—DCK—parotid gland—head and neck cancer	0.000216	0.0124	CbGeAlD
Gemcitabine—RRM2—lymphoid tissue—head and neck cancer	0.000215	0.0124	CbGeAlD
Gemcitabine—POLE—head—head and neck cancer	0.000211	0.0121	CbGeAlD
Gemcitabine—Febrile neutropenia—Docetaxel—head and neck cancer	0.00021	0.00508	CcSEcCtD
Gemcitabine—DCK—saliva-secreting gland—head and neck cancer	0.000207	0.0119	CbGeAlD
Gemcitabine—ABCC10—parotid gland—head and neck cancer	0.000206	0.0119	CbGeAlD
Gemcitabine—Eruption—Docetaxel—head and neck cancer	0.000206	0.00497	CcSEcCtD
Gemcitabine—POLA1—thyroid gland—head and neck cancer	0.000205	0.0118	CbGeAlD
Gemcitabine—Extravasation—Fluorouracil—head and neck cancer	0.000201	0.00486	CcSEcCtD
Gemcitabine—Tenderness—Fluorouracil—head and neck cancer	0.000201	0.00486	CcSEcCtD
Gemcitabine—SLC29A1—connective tissue—head and neck cancer	0.000199	0.0115	CbGeAlD
Gemcitabine—Cerebrovascular accident—Vinblastine—head and neck cancer	0.000198	0.00478	CcSEcCtD
Gemcitabine—POLD1—lymph node—head and neck cancer	0.000197	0.0114	CbGeAlD
Gemcitabine—ABCC10—saliva-secreting gland—head and neck cancer	0.000197	0.0114	CbGeAlD
Gemcitabine—Hepatic failure—Hydroxyurea—head and neck cancer	0.000197	0.00475	CcSEcCtD
Gemcitabine—RRM2—thyroid gland—head and neck cancer	0.000196	0.0113	CbGeAlD
Gemcitabine—Cellulitis—Fluorouracil—head and neck cancer	0.000193	0.00466	CcSEcCtD
Gemcitabine—Ulcer—Fluorouracil—head and neck cancer	0.000185	0.00448	CcSEcCtD
Gemcitabine—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.000185	0.00447	CcSEcCtD
Gemcitabine—TYMS—Vinorelbine—Vinblastine—head and neck cancer	0.000182	0.174	CbGdCrCtD
Gemcitabine—RRM1—lymphoid tissue—head and neck cancer	0.000179	0.0103	CbGeAlD
Gemcitabine—Interstitial lung disease—Docetaxel—head and neck cancer	0.000179	0.00432	CcSEcCtD
Gemcitabine—CDA—lymph node—head and neck cancer	0.000177	0.0102	CbGeAlD
Gemcitabine—RRM2—head—head and neck cancer	0.000174	0.01	CbGeAlD
Gemcitabine—Dermatitis atopic—Docetaxel—head and neck cancer	0.000171	0.00413	CcSEcCtD
Gemcitabine—Face oedema—Hydroxyurea—head and neck cancer	0.000171	0.00412	CcSEcCtD
Gemcitabine—Neuritis—Docetaxel—head and neck cancer	0.000169	0.0041	CcSEcCtD
Gemcitabine—SLC29A1—trachea—head and neck cancer	0.000167	0.00962	CbGeAlD
Gemcitabine—SLC29A2—lymph node—head and neck cancer	0.000166	0.00954	CbGeAlD
Gemcitabine—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.000165	0.004	CcSEcCtD
Gemcitabine—Pleural effusion—Docetaxel—head and neck cancer	0.000165	0.00399	CcSEcCtD
Gemcitabine—Hepatotoxicity—Docetaxel—head and neck cancer	0.000164	0.00396	CcSEcCtD
Gemcitabine—RRM1—thyroid gland—head and neck cancer	0.000163	0.00936	CbGeAlD
Gemcitabine—TYMS—lymphoid tissue—head and neck cancer	0.000162	0.00934	CbGeAlD
Gemcitabine—DCK—trachea—head and neck cancer	0.00016	0.00919	CbGeAlD
Gemcitabine—Pancytopenia—Vinblastine—head and neck cancer	0.000159	0.00385	CcSEcCtD
Gemcitabine—CMPK1—lymph node—head and neck cancer	0.000158	0.00907	CbGeAlD
Gemcitabine—TYMS—Vincristine—Vinblastine—head and neck cancer	0.000156	0.149	CbGdCrCtD
Gemcitabine—ABCC10—trachea—head and neck cancer	0.000152	0.00876	CbGeAlD
Gemcitabine—Sepsis—Fluorouracil—head and neck cancer	0.000152	0.00368	CcSEcCtD
Gemcitabine—POLE—lymph node—head and neck cancer	0.000148	0.0085	CbGeAlD
Gemcitabine—TYMS—thyroid gland—head and neck cancer	0.000147	0.00849	CbGeAlD
Gemcitabine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000147	0.00356	CcSEcCtD
Gemcitabine—Myocardial infarction—Vinblastine—head and neck cancer	0.000146	0.00354	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000146	0.00354	CcSEcCtD
Gemcitabine—SLC29A1—lymphoid tissue—head and neck cancer	0.000146	0.00838	CbGeAlD
Gemcitabine—Pancytopenia—Hydroxyurea—head and neck cancer	0.000145	0.00351	CcSEcCtD
Gemcitabine—Extravasation—Docetaxel—head and neck cancer	0.000145	0.0035	CcSEcCtD
Gemcitabine—RRM1—head—head and neck cancer	0.000144	0.0083	CbGeAlD
Gemcitabine—Neutropenia—Hydroxyurea—head and neck cancer	0.000143	0.00345	CcSEcCtD
Gemcitabine—Bone disorder—Docetaxel—head and neck cancer	0.00014	0.00339	CcSEcCtD
Gemcitabine—Agranulocytosis—Vinblastine—head and neck cancer	0.000139	0.00337	CcSEcCtD
Gemcitabine—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.000139	0.00336	CcSEcCtD
Gemcitabine—DCK—lymphoid tissue—head and neck cancer	0.000139	0.00801	CbGeAlD
Gemcitabine—Drug interaction—Docetaxel—head and neck cancer	0.000136	0.0033	CcSEcCtD
Gemcitabine—Haemoglobin—Vinblastine—head and neck cancer	0.000135	0.00326	CcSEcCtD
Gemcitabine—Haemorrhage—Vinblastine—head and neck cancer	0.000134	0.00324	CcSEcCtD
Gemcitabine—Blood bilirubin increased—Docetaxel—head and neck cancer	0.000134	0.00323	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000133	0.00323	CcSEcCtD
Gemcitabine—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000133	0.00322	CcSEcCtD
Gemcitabine—Pharyngitis—Vinblastine—head and neck cancer	0.000133	0.00322	CcSEcCtD
Gemcitabine—Hearing impaired—Docetaxel—head and neck cancer	0.000133	0.00321	CcSEcCtD
Gemcitabine—Stomatitis—Hydroxyurea—head and neck cancer	0.000133	0.00321	CcSEcCtD
Gemcitabine—ABCC10—lymphoid tissue—head and neck cancer	0.000132	0.00763	CbGeAlD
Gemcitabine—SLC29A1—thyroid gland—head and neck cancer	0.000132	0.00761	CbGeAlD
Gemcitabine—Bone pain—Docetaxel—head and neck cancer	0.000132	0.00319	CcSEcCtD
Gemcitabine—TYMS—head—head and neck cancer	0.000131	0.00753	CbGeAlD
Gemcitabine—Cardiac failure—Fluorouracil—head and neck cancer	0.00013	0.00315	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000129	0.00311	CcSEcCtD
Gemcitabine—Respiratory failure—Docetaxel—head and neck cancer	0.000129	0.00311	CcSEcCtD
Gemcitabine—POLA1—lymph node—head and neck cancer	0.000127	0.00733	CbGeAlD
Gemcitabine—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.000126	0.00306	CcSEcCtD
Gemcitabine—DCK—thyroid gland—head and neck cancer	0.000126	0.00727	CbGeAlD
Gemcitabine—Injection site reaction—Docetaxel—head and neck cancer	0.000126	0.00304	CcSEcCtD
Gemcitabine—Haemoglobin—Hydroxyurea—head and neck cancer	0.000123	0.00297	CcSEcCtD
Gemcitabine—Influenza like illness—Docetaxel—head and neck cancer	0.000123	0.00297	CcSEcCtD
Gemcitabine—Haemorrhage—Hydroxyurea—head and neck cancer	0.000122	0.00296	CcSEcCtD
Gemcitabine—RRM2—lymph node—head and neck cancer	0.000122	0.007	CbGeAlD
Gemcitabine—Skin exfoliation—Docetaxel—head and neck cancer	0.000121	0.00292	CcSEcCtD
Gemcitabine—ABCC10—thyroid gland—head and neck cancer	0.00012	0.00693	CbGeAlD
Gemcitabine—Fluid retention—Docetaxel—head and neck cancer	0.00012	0.0029	CcSEcCtD
Gemcitabine—Neuropathy—Docetaxel—head and neck cancer	0.000119	0.00287	CcSEcCtD
Gemcitabine—Alopecia—Vinblastine—head and neck cancer	0.000118	0.00286	CcSEcCtD
Gemcitabine—SLC29A1—head—head and neck cancer	0.000117	0.00675	CbGeAlD
Gemcitabine—Pulmonary oedema—Docetaxel—head and neck cancer	0.000113	0.00272	CcSEcCtD
Gemcitabine—DCK—head—head and neck cancer	0.000112	0.00645	CbGeAlD
Gemcitabine—Angiopathy—Hydroxyurea—head and neck cancer	0.000111	0.00268	CcSEcCtD
Gemcitabine—Sepsis—Docetaxel—head and neck cancer	0.00011	0.00265	CcSEcCtD
Gemcitabine—Chills—Hydroxyurea—head and neck cancer	0.00011	0.00265	CcSEcCtD
Gemcitabine—Ill-defined disorder—Vinblastine—head and neck cancer	0.000108	0.00262	CcSEcCtD
Gemcitabine—Alopecia—Hydroxyurea—head and neck cancer	0.000108	0.00261	CcSEcCtD
Gemcitabine—Anaemia—Vinblastine—head and neck cancer	0.000108	0.00261	CcSEcCtD
Gemcitabine—Erythema—Hydroxyurea—head and neck cancer	0.000106	0.00257	CcSEcCtD
Gemcitabine—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000106	0.00255	CcSEcCtD
Gemcitabine—Malaise—Vinblastine—head and neck cancer	0.000105	0.00254	CcSEcCtD
Gemcitabine—Leukopenia—Vinblastine—head and neck cancer	0.000104	0.00253	CcSEcCtD
Gemcitabine—Pancytopenia—Fluorouracil—head and neck cancer	0.000104	0.00252	CcSEcCtD
Gemcitabine—Deafness—Docetaxel—head and neck cancer	0.000103	0.00248	CcSEcCtD
Gemcitabine—Hepatic failure—Docetaxel—head and neck cancer	0.000102	0.00247	CcSEcCtD
Gemcitabine—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000101	0.00245	CcSEcCtD
Gemcitabine—RRM1—lymph node—head and neck cancer	0.000101	0.00581	CbGeAlD
Gemcitabine—Hypertension—Vinblastine—head and neck cancer	0.000101	0.00244	CcSEcCtD
Gemcitabine—Ill-defined disorder—Hydroxyurea—head and neck cancer	9.87e-05	0.00239	CcSEcCtD
Gemcitabine—Pneumonia—Fluorouracil—head and neck cancer	9.86e-05	0.00238	CcSEcCtD
Gemcitabine—Anaemia—Hydroxyurea—head and neck cancer	9.83e-05	0.00238	CcSEcCtD
Gemcitabine—Discomfort—Vinblastine—head and neck cancer	9.81e-05	0.00237	CcSEcCtD
Gemcitabine—Acute coronary syndrome—Fluorouracil—head and neck cancer	9.66e-05	0.00234	CcSEcCtD
Gemcitabine—Renal impairment—Docetaxel—head and neck cancer	9.64e-05	0.00233	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Fluorouracil—head and neck cancer	9.61e-05	0.00232	CcSEcCtD
Gemcitabine—Myocardial infarction—Fluorouracil—head and neck cancer	9.61e-05	0.00232	CcSEcCtD
Gemcitabine—Dermatitis bullous—Docetaxel—head and neck cancer	9.6e-05	0.00232	CcSEcCtD
Gemcitabine—Malaise—Hydroxyurea—head and neck cancer	9.59e-05	0.00232	CcSEcCtD
Gemcitabine—Stomatitis—Fluorouracil—head and neck cancer	9.55e-05	0.00231	CcSEcCtD
Gemcitabine—Leukopenia—Hydroxyurea—head and neck cancer	9.52e-05	0.0023	CcSEcCtD
Gemcitabine—Cardiac failure—Docetaxel—head and neck cancer	9.4e-05	0.00227	CcSEcCtD
Gemcitabine—Thrombocytopenia—Vinblastine—head and neck cancer	9.32e-05	0.00225	CcSEcCtD
Gemcitabine—TYMS—lymph node—head and neck cancer	9.16e-05	0.00527	CbGeAlD
Gemcitabine—Agranulocytosis—Fluorouracil—head and neck cancer	9.14e-05	0.00221	CcSEcCtD
Gemcitabine—Anorexia—Vinblastine—head and neck cancer	9.08e-05	0.00219	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	8.99e-05	0.00218	CcSEcCtD
Gemcitabine—Discomfort—Hydroxyurea—head and neck cancer	8.95e-05	0.00216	CcSEcCtD
Gemcitabine—Haemoglobin—Fluorouracil—head and neck cancer	8.84e-05	0.00214	CcSEcCtD
Gemcitabine—Rhinitis—Fluorouracil—head and neck cancer	8.82e-05	0.00213	CcSEcCtD
Gemcitabine—Haemorrhage—Fluorouracil—head and neck cancer	8.8e-05	0.00213	CcSEcCtD
Gemcitabine—Pharyngitis—Fluorouracil—head and neck cancer	8.73e-05	0.00211	CcSEcCtD
Gemcitabine—Oedema—Hydroxyurea—head and neck cancer	8.68e-05	0.0021	CcSEcCtD
Gemcitabine—Infection—Hydroxyurea—head and neck cancer	8.63e-05	0.00209	CcSEcCtD
Gemcitabine—Paraesthesia—Vinblastine—head and neck cancer	8.55e-05	0.00207	CcSEcCtD
Gemcitabine—Nervous system disorder—Hydroxyurea—head and neck cancer	8.51e-05	0.00206	CcSEcCtD
Gemcitabine—Thrombocytopenia—Hydroxyurea—head and neck cancer	8.5e-05	0.00206	CcSEcCtD
Gemcitabine—Liver function test abnormal—Docetaxel—head and neck cancer	8.47e-05	0.00205	CcSEcCtD
Gemcitabine—Skin disorder—Hydroxyurea—head and neck cancer	8.43e-05	0.00204	CcSEcCtD
Gemcitabine—Anorexia—Hydroxyurea—head and neck cancer	8.28e-05	0.002	CcSEcCtD
Gemcitabine—Decreased appetite—Vinblastine—head and neck cancer	8.28e-05	0.002	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	8.26e-05	0.002	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	8.26e-05	0.002	CcSEcCtD
Gemcitabine—SLC29A1—lymph node—head and neck cancer	8.21e-05	0.00473	CbGeAlD
Gemcitabine—Pain—Vinblastine—head and neck cancer	8.14e-05	0.00197	CcSEcCtD
Gemcitabine—Constipation—Vinblastine—head and neck cancer	8.14e-05	0.00197	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	8.09e-05	0.00196	CcSEcCtD
Gemcitabine—RRM2—Fluoropyrimidine Activity—TP53—head and neck cancer	7.89e-05	0.00226	CbGpPWpGaD
Gemcitabine—Arrhythmia—Fluorouracil—head and neck cancer	7.86e-05	0.0019	CcSEcCtD
Gemcitabine—Feeling abnormal—Vinblastine—head and neck cancer	7.85e-05	0.0019	CcSEcCtD
Gemcitabine—DCK—lymph node—head and neck cancer	7.84e-05	0.00452	CbGeAlD
Gemcitabine—Bronchospasm—Docetaxel—head and neck cancer	7.8e-05	0.00189	CcSEcCtD
Gemcitabine—Alopecia—Fluorouracil—head and neck cancer	7.77e-05	0.00188	CcSEcCtD
Gemcitabine—Dyspnoea—Hydroxyurea—head and neck cancer	7.74e-05	0.00187	CcSEcCtD
Gemcitabine—Somnolence—Hydroxyurea—head and neck cancer	7.72e-05	0.00187	CcSEcCtD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—TYMS—head and neck cancer	7.71e-05	0.00221	CbGpPWpGaD
Gemcitabine—Erythema—Fluorouracil—head and neck cancer	7.66e-05	0.00185	CcSEcCtD
Gemcitabine—Decreased appetite—Hydroxyurea—head and neck cancer	7.55e-05	0.00183	CcSEcCtD
Gemcitabine—Pancytopenia—Docetaxel—head and neck cancer	7.53e-05	0.00182	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	7.5e-05	0.00181	CcSEcCtD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	7.49e-05	0.00215	CbGpPWpGaD
Gemcitabine—Fatigue—Hydroxyurea—head and neck cancer	7.49e-05	0.00181	CcSEcCtD
Gemcitabine—ABCC10—lymph node—head and neck cancer	7.47e-05	0.0043	CbGeAlD
Gemcitabine—Pain—Hydroxyurea—head and neck cancer	7.42e-05	0.0018	CcSEcCtD
Gemcitabine—Constipation—Hydroxyurea—head and neck cancer	7.42e-05	0.0018	CcSEcCtD
Gemcitabine—Neutropenia—Docetaxel—head and neck cancer	7.42e-05	0.00179	CcSEcCtD
Gemcitabine—TYMS—Nucleotide metabolism—GPX1—head and neck cancer	7.41e-05	0.00213	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—TYMS—head and neck cancer	7.4e-05	0.00212	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	7.31e-05	0.0021	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Hydroxyurea—head and neck cancer	7.15e-05	0.00173	CcSEcCtD
Gemcitabine—Pneumonia—Docetaxel—head and neck cancer	7.11e-05	0.00172	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	7.09e-05	0.00203	CbGpPWpGaD
Gemcitabine—Anaemia—Fluorouracil—head and neck cancer	7.08e-05	0.00171	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	7.01e-05	0.0017	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	7e-05	0.00201	CbGpPWpGaD
Gemcitabine—Acute coronary syndrome—Docetaxel—head and neck cancer	6.97e-05	0.00169	CcSEcCtD
Gemcitabine—Renal failure—Docetaxel—head and neck cancer	6.95e-05	0.00168	CcSEcCtD
Gemcitabine—Myocardial infarction—Docetaxel—head and neck cancer	6.93e-05	0.00168	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Docetaxel—head and neck cancer	6.93e-05	0.00168	CcSEcCtD
Gemcitabine—Stomatitis—Docetaxel—head and neck cancer	6.89e-05	0.00167	CcSEcCtD
Gemcitabine—Body temperature increased—Hydroxyurea—head and neck cancer	6.86e-05	0.00166	CcSEcCtD
Gemcitabine—Leukopenia—Fluorouracil—head and neck cancer	6.85e-05	0.00166	CcSEcCtD
Gemcitabine—Asthenia—Vinblastine—head and neck cancer	6.83e-05	0.00165	CcSEcCtD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	6.7e-05	0.00192	CbGpPWpGaD
Gemcitabine—Hepatobiliary disease—Docetaxel—head and neck cancer	6.69e-05	0.00162	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	6.65e-05	0.00191	CbGpPWpGaD
Gemcitabine—Agranulocytosis—Docetaxel—head and neck cancer	6.6e-05	0.0016	CcSEcCtD
Gemcitabine—Myalgia—Fluorouracil—head and neck cancer	6.52e-05	0.00158	CcSEcCtD
Gemcitabine—Chest pain—Fluorouracil—head and neck cancer	6.52e-05	0.00158	CcSEcCtD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	6.52e-05	0.00187	CbGpPWpGaD
Gemcitabine—Diarrhoea—Vinblastine—head and neck cancer	6.51e-05	0.00158	CcSEcCtD
Gemcitabine—POLE—G1 to S cell cycle control—CCND1—head and neck cancer	6.45e-05	0.00185	CbGpPWpGaD
Gemcitabine—Discomfort—Fluorouracil—head and neck cancer	6.44e-05	0.00156	CcSEcCtD
Gemcitabine—Haemoglobin—Docetaxel—head and neck cancer	6.38e-05	0.00154	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	6.37e-05	0.00183	CbGpPWpGaD
Gemcitabine—Rhinitis—Docetaxel—head and neck cancer	6.37e-05	0.00154	CcSEcCtD
Gemcitabine—RRM1—Metabolism—UROD—head and neck cancer	6.35e-05	0.00182	CbGpPWpGaD
Gemcitabine—Haemorrhage—Docetaxel—head and neck cancer	6.35e-05	0.00154	CcSEcCtD
Gemcitabine—Pharyngitis—Docetaxel—head and neck cancer	6.3e-05	0.00152	CcSEcCtD
Gemcitabine—Urinary tract disorder—Docetaxel—head and neck cancer	6.27e-05	0.00152	CcSEcCtD
Gemcitabine—POLA1—G1/S Transition—TYMS—head and neck cancer	6.26e-05	0.00179	CbGpPWpGaD
Gemcitabine—Oedema peripheral—Docetaxel—head and neck cancer	6.25e-05	0.00151	CcSEcCtD
Gemcitabine—Oedema—Fluorouracil—head and neck cancer	6.25e-05	0.00151	CcSEcCtD
Gemcitabine—Anaphylactic shock—Fluorouracil—head and neck cancer	6.25e-05	0.00151	CcSEcCtD
Gemcitabine—Connective tissue disorder—Docetaxel—head and neck cancer	6.24e-05	0.00151	CcSEcCtD
Gemcitabine—Asthenia—Hydroxyurea—head and neck cancer	6.23e-05	0.00151	CcSEcCtD
Gemcitabine—Urethral disorder—Docetaxel—head and neck cancer	6.22e-05	0.00151	CcSEcCtD
Gemcitabine—Infection—Fluorouracil—head and neck cancer	6.21e-05	0.0015	CcSEcCtD
Gemcitabine—Nervous system disorder—Fluorouracil—head and neck cancer	6.13e-05	0.00148	CcSEcCtD
Gemcitabine—Thrombocytopenia—Fluorouracil—head and neck cancer	6.12e-05	0.00148	CcSEcCtD
Gemcitabine—Vomiting—Vinblastine—head and neck cancer	6.05e-05	0.00146	CcSEcCtD
Gemcitabine—Erythema multiforme—Docetaxel—head and neck cancer	6e-05	0.00145	CcSEcCtD
Gemcitabine—Headache—Vinblastine—head and neck cancer	5.96e-05	0.00144	CcSEcCtD
Gemcitabine—Anorexia—Fluorouracil—head and neck cancer	5.96e-05	0.00144	CcSEcCtD
Gemcitabine—Diarrhoea—Hydroxyurea—head and neck cancer	5.94e-05	0.00144	CcSEcCtD
Gemcitabine—Cardiac disorder—Docetaxel—head and neck cancer	5.89e-05	0.00143	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CCNA1—head and neck cancer	5.86e-05	0.00168	CbGpPWpGaD
Gemcitabine—Hypotension—Fluorouracil—head and neck cancer	5.84e-05	0.00141	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CCNA1—head and neck cancer	5.82e-05	0.00167	CbGpPWpGaD
Gemcitabine—Angiopathy—Docetaxel—head and neck cancer	5.76e-05	0.00139	CcSEcCtD
Gemcitabine—Immune system disorder—Docetaxel—head and neck cancer	5.73e-05	0.00139	CcSEcCtD
Gemcitabine—Mediastinal disorder—Docetaxel—head and neck cancer	5.72e-05	0.00138	CcSEcCtD
Gemcitabine—Chills—Docetaxel—head and neck cancer	5.7e-05	0.00138	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	5.69e-05	0.00138	CcSEcCtD
Gemcitabine—Arrhythmia—Docetaxel—head and neck cancer	5.67e-05	0.00137	CcSEcCtD
Gemcitabine—Nausea—Vinblastine—head and neck cancer	5.66e-05	0.00137	CcSEcCtD
Gemcitabine—Insomnia—Fluorouracil—head and neck cancer	5.65e-05	0.00137	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—NAT2—head and neck cancer	5.64e-05	0.00162	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CCNA1—head and neck cancer	5.62e-05	0.00161	CbGpPWpGaD
Gemcitabine—Paraesthesia—Fluorouracil—head and neck cancer	5.61e-05	0.00136	CcSEcCtD
Gemcitabine—Alopecia—Docetaxel—head and neck cancer	5.61e-05	0.00136	CcSEcCtD
Gemcitabine—Dyspnoea—Fluorouracil—head and neck cancer	5.57e-05	0.00135	CcSEcCtD
Gemcitabine—Somnolence—Fluorouracil—head and neck cancer	5.56e-05	0.00134	CcSEcCtD
Gemcitabine—Erythema—Docetaxel—head and neck cancer	5.53e-05	0.00134	CcSEcCtD
Gemcitabine—Vomiting—Hydroxyurea—head and neck cancer	5.52e-05	0.00134	CcSEcCtD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	5.51e-05	0.00158	CbGpPWpGaD
Gemcitabine—Rash—Hydroxyurea—head and neck cancer	5.47e-05	0.00132	CcSEcCtD
Gemcitabine—Dermatitis—Hydroxyurea—head and neck cancer	5.47e-05	0.00132	CcSEcCtD
Gemcitabine—Headache—Hydroxyurea—head and neck cancer	5.44e-05	0.00132	CcSEcCtD
Gemcitabine—Decreased appetite—Fluorouracil—head and neck cancer	5.43e-05	0.00131	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	5.4e-05	0.0013	CcSEcCtD
Gemcitabine—Back pain—Docetaxel—head and neck cancer	5.35e-05	0.00129	CcSEcCtD
Gemcitabine—Pain—Fluorouracil—head and neck cancer	5.34e-05	0.00129	CcSEcCtD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	5.29e-05	0.00152	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—TYMS—head and neck cancer	5.27e-05	0.00151	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CCNA1—head and neck cancer	5.24e-05	0.0015	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—UROD—head and neck cancer	5.23e-05	0.0015	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CCNA1—head and neck cancer	5.21e-05	0.00149	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—UROD—head and neck cancer	5.2e-05	0.00149	CbGpPWpGaD
Gemcitabine—TYMS—Fluoropyrimidine Activity—TP53—head and neck cancer	5.17e-05	0.00148	CbGpPWpGaD
Gemcitabine—Nausea—Hydroxyurea—head and neck cancer	5.16e-05	0.00125	CcSEcCtD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	5.15e-05	0.00148	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Fluorouracil—head and neck cancer	5.15e-05	0.00125	CcSEcCtD
Gemcitabine—Anaemia—Docetaxel—head and neck cancer	5.11e-05	0.00124	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—CCNA1—head and neck cancer	5.03e-05	0.00144	CbGpPWpGaD
Gemcitabine—ABCB1—epithelium—head and neck cancer	4.97e-05	0.00286	CbGeAlD
Gemcitabine—Leukopenia—Docetaxel—head and neck cancer	4.95e-05	0.0012	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—DPYD—head and neck cancer	4.94e-05	0.00142	CbGpPWpGaD
Gemcitabine—Body temperature increased—Fluorouracil—head and neck cancer	4.94e-05	0.00119	CcSEcCtD
Gemcitabine—DCK—Metabolism—UROD—head and neck cancer	4.89e-05	0.0014	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	4.85e-05	0.00139	CbGpPWpGaD
Gemcitabine—Cough—Docetaxel—head and neck cancer	4.82e-05	0.00117	CcSEcCtD
Gemcitabine—Hypertension—Docetaxel—head and neck cancer	4.77e-05	0.00115	CcSEcCtD
Gemcitabine—Myalgia—Docetaxel—head and neck cancer	4.71e-05	0.00114	CcSEcCtD
Gemcitabine—Arthralgia—Docetaxel—head and neck cancer	4.71e-05	0.00114	CcSEcCtD
Gemcitabine—Chest pain—Docetaxel—head and neck cancer	4.71e-05	0.00114	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—YAP1—head and neck cancer	4.69e-05	0.00135	CbGpPWpGaD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	4.67e-05	0.00113	CcSEcCtD
Gemcitabine—Anaphylactic shock—Docetaxel—head and neck cancer	4.51e-05	0.00109	CcSEcCtD
Gemcitabine—Oedema—Docetaxel—head and neck cancer	4.51e-05	0.00109	CcSEcCtD
Gemcitabine—Infection—Docetaxel—head and neck cancer	4.48e-05	0.00108	CcSEcCtD
Gemcitabine—Nervous system disorder—Docetaxel—head and neck cancer	4.42e-05	0.00107	CcSEcCtD
Gemcitabine—Pruritus—Fluorouracil—head and neck cancer	4.42e-05	0.00107	CcSEcCtD
Gemcitabine—Thrombocytopenia—Docetaxel—head and neck cancer	4.42e-05	0.00107	CcSEcCtD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	4.41e-05	0.00127	CbGpPWpGaD
Gemcitabine—ABCB1—trachea—head and neck cancer	4.39e-05	0.00253	CbGeAlD
Gemcitabine—Skin disorder—Docetaxel—head and neck cancer	4.38e-05	0.00106	CcSEcCtD
Gemcitabine—Anorexia—Docetaxel—head and neck cancer	4.3e-05	0.00104	CcSEcCtD
Gemcitabine—Diarrhoea—Fluorouracil—head and neck cancer	4.28e-05	0.00103	CcSEcCtD
Gemcitabine—POLE—G1 to S cell cycle control—TP53—head and neck cancer	4.25e-05	0.00122	CbGpPWpGaD
Gemcitabine—Hypotension—Docetaxel—head and neck cancer	4.22e-05	0.00102	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—RAD51—head and neck cancer	4.21e-05	0.00121	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—RAD51—head and neck cancer	4.18e-05	0.0012	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	4.16e-05	0.00119	CbGpPWpGaD
Gemcitabine—POLD1—S Phase—CCND1—head and neck cancer	4.15e-05	0.00119	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	4.11e-05	0.000994	CcSEcCtD
Gemcitabine—Insomnia—Docetaxel—head and neck cancer	4.08e-05	0.000987	CcSEcCtD
Gemcitabine—Paraesthesia—Docetaxel—head and neck cancer	4.05e-05	0.00098	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—RAD51—head and neck cancer	4.04e-05	0.00116	CbGpPWpGaD
Gemcitabine—Dyspnoea—Docetaxel—head and neck cancer	4.02e-05	0.000973	CcSEcCtD
Gemcitabine—POLE—S Phase—CCND1—head and neck cancer	4.01e-05	0.00115	CbGpPWpGaD
Gemcitabine—Somnolence—Docetaxel—head and neck cancer	4.01e-05	0.00097	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCNA1—head and neck cancer	4.01e-05	0.00115	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	3.99e-05	0.00115	CbGpPWpGaD
Gemcitabine—Vomiting—Fluorouracil—head and neck cancer	3.97e-05	0.000961	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	3.95e-05	0.00113	CbGpPWpGaD
Gemcitabine—Rash—Fluorouracil—head and neck cancer	3.94e-05	0.000953	CcSEcCtD
Gemcitabine—Dermatitis—Fluorouracil—head and neck cancer	3.94e-05	0.000952	CcSEcCtD
Gemcitabine—Decreased appetite—Docetaxel—head and neck cancer	3.92e-05	0.000948	CcSEcCtD
Gemcitabine—Headache—Fluorouracil—head and neck cancer	3.92e-05	0.000947	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Docetaxel—head and neck cancer	3.89e-05	0.000942	CcSEcCtD
Gemcitabine—Fatigue—Docetaxel—head and neck cancer	3.89e-05	0.000941	CcSEcCtD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—CCND1—head and neck cancer	3.88e-05	0.00111	CbGpPWpGaD
Gemcitabine—Constipation—Docetaxel—head and neck cancer	3.86e-05	0.000933	CcSEcCtD
Gemcitabine—Pain—Docetaxel—head and neck cancer	3.86e-05	0.000933	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCNA1—head and neck cancer	3.84e-05	0.0011	CbGpPWpGaD
Gemcitabine—ABCB1—lymphoid tissue—head and neck cancer	3.82e-05	0.0022	CbGeAlD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	3.77e-05	0.00108	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—CCND1—head and neck cancer	3.72e-05	0.00107	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Docetaxel—head and neck cancer	3.72e-05	0.000899	CcSEcCtD
Gemcitabine—Nausea—Fluorouracil—head and neck cancer	3.71e-05	0.000898	CcSEcCtD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	3.63e-05	0.00104	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	3.61e-05	0.00104	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCNA1—head and neck cancer	3.58e-05	0.00103	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	3.57e-05	0.00102	CbGpPWpGaD
Gemcitabine—Body temperature increased—Docetaxel—head and neck cancer	3.57e-05	0.000862	CcSEcCtD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	3.49e-05	0.001	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—NAT2—head and neck cancer	3.48e-05	0.000999	CbGpPWpGaD
Gemcitabine—ABCB1—thyroid gland—head and neck cancer	3.47e-05	0.002	CbGeAlD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	3.45e-05	0.000989	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCNA1—head and neck cancer	3.43e-05	0.000985	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—UROD—head and neck cancer	3.43e-05	0.000984	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	3.39e-05	0.000974	CbGpPWpGaD
Gemcitabine—Asthenia—Docetaxel—head and neck cancer	3.24e-05	0.000783	CcSEcCtD
Gemcitabine—Pruritus—Docetaxel—head and neck cancer	3.19e-05	0.000772	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.11e-05	0.000893	CbGpPWpGaD
Gemcitabine—Diarrhoea—Docetaxel—head and neck cancer	3.09e-05	0.000746	CcSEcCtD
Gemcitabine—ABCB1—head—head and neck cancer	3.08e-05	0.00177	CbGeAlD
Gemcitabine—CDA—Metabolism—DPYD—head and neck cancer	3.05e-05	0.000876	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	2.94e-05	0.000845	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—YAP1—head and neck cancer	2.9e-05	0.000831	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—RAD51—head and neck cancer	2.88e-05	0.000826	CbGpPWpGaD
Gemcitabine—Vomiting—Docetaxel—head and neck cancer	2.87e-05	0.000694	CcSEcCtD
Gemcitabine—POLA1—S Phase—CCND1—head and neck cancer	2.86e-05	0.00082	CbGpPWpGaD
Gemcitabine—Rash—Docetaxel—head and neck cancer	2.84e-05	0.000688	CcSEcCtD
Gemcitabine—Dermatitis—Docetaxel—head and neck cancer	2.84e-05	0.000687	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—TYMS—head and neck cancer	2.83e-05	0.000811	CbGpPWpGaD
Gemcitabine—Headache—Docetaxel—head and neck cancer	2.83e-05	0.000683	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—TYMS—head and neck cancer	2.82e-05	0.000808	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—TYMS—head and neck cancer	2.81e-05	0.000806	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.8e-05	0.000804	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.8e-05	0.000804	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GSTM1—head and neck cancer	2.78e-05	0.000799	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—RAD51—head and neck cancer	2.76e-05	0.000791	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	2.73e-05	0.000783	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—TYMS—head and neck cancer	2.71e-05	0.000779	CbGpPWpGaD
Gemcitabine—Nausea—Docetaxel—head and neck cancer	2.68e-05	0.000648	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—GPX1—head and neck cancer	2.67e-05	0.000765	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CCND1—head and neck cancer	2.65e-05	0.000762	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—NAT2—head and neck cancer	2.64e-05	0.000757	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CYP1A1—head and neck cancer	2.64e-05	0.000757	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	2.62e-05	0.000751	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CCND1—head and neck cancer	2.54e-05	0.00073	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TYMS—head and neck cancer	2.53e-05	0.000725	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TYMS—head and neck cancer	2.51e-05	0.000721	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	2.48e-05	0.000713	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.43e-05	0.000698	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TYMS—head and neck cancer	2.43e-05	0.000696	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	2.38e-05	0.000683	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.35e-05	0.000675	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	2.34e-05	0.000672	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—DPYD—head and neck cancer	2.31e-05	0.000664	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	2.24e-05	0.000644	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	2.23e-05	0.000639	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—YAP1—head and neck cancer	2.2e-05	0.00063	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—NAT2—head and neck cancer	2.17e-05	0.000624	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	2.16e-05	0.00062	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—NAT2—head and neck cancer	2.16e-05	0.00062	CbGpPWpGaD
Gemcitabine—ABCB1—lymph node—head and neck cancer	2.16e-05	0.00124	CbGeAlD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	2.13e-05	0.000612	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—NAT2—head and neck cancer	2.03e-05	0.000583	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	2.01e-05	0.000577	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.99e-05	0.00057	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	1.97e-05	0.000564	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.94e-05	0.000557	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—TYMS—head and neck cancer	1.93e-05	0.000555	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	1.93e-05	0.000553	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—DPYD—head and neck cancer	1.91e-05	0.000547	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—DPYD—head and neck cancer	1.89e-05	0.000543	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.86e-05	0.000534	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—YAP1—head and neck cancer	1.81e-05	0.000519	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—YAP1—head and neck cancer	1.8e-05	0.000516	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—PTEN—head and neck cancer	1.78e-05	0.000512	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—DPYD—head and neck cancer	1.78e-05	0.000511	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.75e-05	0.000503	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—TYMS—head and neck cancer	1.74e-05	0.000499	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TYMS—head and neck cancer	1.73e-05	0.000496	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GSTM1—head and neck cancer	1.72e-05	0.000493	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—YAP1—head and neck cancer	1.69e-05	0.000485	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.68e-05	0.000482	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.66e-05	0.000476	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GPX1—head and neck cancer	1.65e-05	0.000473	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CASP8—head and neck cancer	1.64e-05	0.000469	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CYP1A1—head and neck cancer	1.63e-05	0.000468	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.59e-05	0.000456	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.58e-05	0.000453	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.58e-05	0.000453	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTGS2—head and neck cancer	1.57e-05	0.00045	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.51e-05	0.000434	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.51e-05	0.000434	CbGpPWpGaD
Gemcitabine—POLE—Mitotic M-M/G1 phases—MAPK3—head and neck cancer	1.51e-05	0.000432	CbGpPWpGaD
Gemcitabine—POLE—Mitotic M-M/G1 phases—MAPK1—head and neck cancer	1.43e-05	0.000411	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NAT2—head and neck cancer	1.42e-05	0.000409	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CCND1—head and neck cancer	1.42e-05	0.000408	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CCND1—head and neck cancer	1.41e-05	0.000406	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.37e-05	0.000393	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTEN—head and neck cancer	1.37e-05	0.000393	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CCND1—head and neck cancer	1.37e-05	0.000392	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.32e-05	0.00038	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—TYMS—head and neck cancer	1.32e-05	0.000378	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.31e-05	0.000376	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTM1—head and neck cancer	1.3e-05	0.000374	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CCND1—head and neck cancer	1.27e-05	0.000365	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.27e-05	0.000364	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CCND1—head and neck cancer	1.26e-05	0.000363	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—DPYD—head and neck cancer	1.25e-05	0.000358	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GPX1—head and neck cancer	1.25e-05	0.000358	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL2—head and neck cancer	1.24e-05	0.000355	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP1A1—head and neck cancer	1.24e-05	0.000355	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CCND1—head and neck cancer	1.22e-05	0.000351	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—head and neck cancer	1.22e-05	0.00035	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	1.21e-05	0.000348	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	1.19e-05	0.000341	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—YAP1—head and neck cancer	1.18e-05	0.00034	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	1.18e-05	0.000339	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MAPK3—head and neck cancer	1.17e-05	0.000337	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MAPK3—head and neck cancer	1.17e-05	0.000335	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MAPK3—head and neck cancer	1.13e-05	0.000323	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.12e-05	0.000321	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MAPK1—head and neck cancer	1.12e-05	0.00032	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MAPK1—head and neck cancer	1.11e-05	0.000319	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—TYMS—head and neck cancer	1.09e-05	0.000312	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—TYMS—head and neck cancer	1.08e-05	0.00031	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—MAPK3—head and neck cancer	1.07e-05	0.000308	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTM1—head and neck cancer	1.07e-05	0.000308	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MAPK1—head and neck cancer	1.07e-05	0.000308	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.07e-05	0.000307	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTM1—head and neck cancer	1.07e-05	0.000306	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—UROD—head and neck cancer	1.06e-05	0.000304	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	1.05e-05	0.000301	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MAPK3—head and neck cancer	1.05e-05	0.000301	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MAPK3—head and neck cancer	1.04e-05	0.000299	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GPX1—head and neck cancer	1.03e-05	0.000295	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GPX1—head and neck cancer	1.02e-05	0.000293	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—MAPK1—head and neck cancer	1.02e-05	0.000293	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP1A1—head and neck cancer	1.02e-05	0.000292	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—TYMS—head and neck cancer	1.01e-05	0.000291	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP1A1—head and neck cancer	1.01e-05	0.00029	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MAPK3—head and neck cancer	1.01e-05	0.000289	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTM1—head and neck cancer	1e-05	0.000288	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MAPK1—head and neck cancer	9.99e-06	0.000287	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MAPK1—head and neck cancer	9.92e-06	0.000285	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCND1—head and neck cancer	9.73e-06	0.000279	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—head and neck cancer	9.7e-06	0.000278	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CA—head and neck cancer	9.65e-06	0.000277	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GPX1—head and neck cancer	9.6e-06	0.000276	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MAPK1—head and neck cancer	9.59e-06	0.000275	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP1A1—head and neck cancer	9.51e-06	0.000273	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCND1—head and neck cancer	9.33e-06	0.000268	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCND1—head and neck cancer	8.7e-06	0.00025	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTEN—head and neck cancer	8.46e-06	0.000243	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—head and neck cancer	8.38e-06	0.000241	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND1—head and neck cancer	8.34e-06	0.000239	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—head and neck cancer	8.33e-06	0.000239	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	8.07e-06	0.000232	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—head and neck cancer	8.05e-06	0.000231	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MAPK3—head and neck cancer	8.03e-06	0.00023	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—AKT1—head and neck cancer	7.89e-06	0.000226	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	7.74e-06	0.000222	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MAPK3—head and neck cancer	7.69e-06	0.000221	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MAPK1—head and neck cancer	7.64e-06	0.000219	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—head and neck cancer	7.35e-06	0.000211	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MAPK1—head and neck cancer	7.32e-06	0.00021	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MAPK3—head and neck cancer	7.18e-06	0.000206	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTM1—head and neck cancer	7.03e-06	0.000202	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	6.92e-06	0.000199	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MAPK3—head and neck cancer	6.88e-06	0.000197	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MAPK1—head and neck cancer	6.83e-06	0.000196	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GPX1—head and neck cancer	6.73e-06	0.000193	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP1A1—head and neck cancer	6.67e-06	0.000191	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	6.58e-06	0.000189	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MAPK1—head and neck cancer	6.54e-06	0.000188	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTEN—head and neck cancer	6.41e-06	0.000184	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—head and neck cancer	6.05e-06	0.000174	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—head and neck cancer	6.01e-06	0.000173	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CA—head and neck cancer	5.96e-06	0.000171	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	5.94e-06	0.000171	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	5.74e-06	0.000165	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—head and neck cancer	5.73e-06	0.000165	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—head and neck cancer	5.65e-06	0.000162	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—head and neck cancer	5.49e-06	0.000158	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTEN—head and neck cancer	5.28e-06	0.000151	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTEN—head and neck cancer	5.24e-06	0.00015	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	5.18e-06	0.000149	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTEN—head and neck cancer	4.93e-06	0.000141	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	4.9e-06	0.000141	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—AKT1—head and neck cancer	4.87e-06	0.00014	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	4.66e-06	0.000134	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	4.66e-06	0.000134	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CA—head and neck cancer	4.52e-06	0.00013	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NAT2—head and neck cancer	4.39e-06	0.000126	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.05e-06	0.000116	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—head and neck cancer	3.96e-06	0.000114	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	3.92e-06	0.000112	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—DPYD—head and neck cancer	3.85e-06	0.000111	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CA—head and neck cancer	3.72e-06	0.000107	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CA—head and neck cancer	3.7e-06	0.000106	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AKT1—head and neck cancer	3.69e-06	0.000106	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—YAP1—head and neck cancer	3.66e-06	0.000105	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CA—head and neck cancer	3.48e-06	9.98e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTEN—head and neck cancer	3.46e-06	9.92e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.31e-06	9.49e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKT1—head and neck cancer	3.04e-06	8.73e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKT1—head and neck cancer	3.02e-06	8.67e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKT1—head and neck cancer	2.84e-06	8.15e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CA—head and neck cancer	2.44e-06	7e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TYMS—head and neck cancer	2.2e-06	6.3e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTM1—head and neck cancer	2.17e-06	6.23e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GPX1—head and neck cancer	2.08e-06	5.96e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP1A1—head and neck cancer	2.06e-06	5.9e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKT1—head and neck cancer	1.99e-06	5.72e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—head and neck cancer	1.22e-06	3.51e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTEN—head and neck cancer	1.07e-06	3.06e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CA—head and neck cancer	7.53e-07	2.16e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKT1—head and neck cancer	6.15e-07	1.76e-05	CbGpPWpGaD
